AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,440,051 | -32.2% | 1,472,336 | -15.6% | 0.00% | -33.3% |
| Q2 2023 | $16,883,904 | +55.7% | 1,744,205 | +76.3% | 0.00% | +50.0% |
| Q1 2023 | $10,845,731 | +433.4% | 989,574 | +110.2% | 0.00% | – |
| Q4 2022 | $2,033,481 | -43.0% | 470,713 | -0.7% | 0.00% | -100.0% |
| Q3 2022 | $3,567,000 | -50.7% | 474,240 | -34.2% | 0.00% | -50.0% |
| Q2 2022 | $7,241,000 | +88.9% | 720,434 | +132.6% | 0.00% | +100.0% |
| Q1 2022 | $3,834,000 | -38.7% | 309,707 | +13.3% | 0.00% | 0.0% |
| Q4 2021 | $6,253,000 | +60.5% | 273,422 | +55.3% | 0.00% | 0.0% |
| Q3 2021 | $3,895,000 | +75.4% | 176,045 | +2.7% | 0.00% | – |
| Q2 2021 | $2,221,000 | -42.9% | 171,371 | -42.8% | 0.00% | -100.0% |
| Q1 2021 | $3,891,000 | +64.0% | 299,702 | +74.7% | 0.00% | 0.0% |
| Q4 2020 | $2,373,000 | -10.4% | 171,568 | -4.6% | 0.00% | 0.0% |
| Q3 2020 | $2,648,000 | -39.4% | 179,775 | -33.1% | 0.00% | 0.0% |
| Q2 2020 | $4,368,000 | -50.7% | 268,846 | -55.9% | 0.00% | -66.7% |
| Q1 2020 | $8,855,000 | -29.8% | 610,282 | -2.0% | 0.00% | 0.0% |
| Q4 2019 | $12,618,000 | +42.9% | 622,804 | -62.3% | 0.00% | 0.0% |
| Q3 2019 | $8,831,000 | +18.3% | 1,653,702 | +45.7% | 0.00% | +50.0% |
| Q2 2019 | $7,468,000 | -16.7% | 1,135,028 | -17.7% | 0.00% | -33.3% |
| Q1 2019 | $8,965,000 | -20.9% | 1,379,301 | -17.0% | 0.00% | -25.0% |
| Q4 2018 | $11,340,000 | -2.0% | 1,662,772 | -4.6% | 0.00% | +33.3% |
| Q3 2018 | $11,576,000 | +12.1% | 1,743,340 | -5.0% | 0.00% | 0.0% |
| Q2 2018 | $10,327,000 | +60.2% | 1,834,325 | +47.7% | 0.00% | +50.0% |
| Q1 2018 | $6,446,000 | +19.1% | 1,241,995 | +4.0% | 0.00% | +100.0% |
| Q4 2017 | $5,411,000 | -1.4% | 1,194,550 | +36.5% | 0.00% | 0.0% |
| Q3 2017 | $5,486,000 | +2.1% | 874,911 | -0.2% | 0.00% | 0.0% |
| Q2 2017 | $5,373,000 | +45.9% | 876,461 | +74.7% | 0.00% | 0.0% |
| Q1 2017 | $3,682,000 | +37.5% | 501,645 | -60.6% | 0.00% | 0.0% |
| Q4 2016 | $2,677,000 | +136.9% | 1,274,696 | +239.6% | 0.00% | – |
| Q3 2016 | $1,130,000 | +1752.5% | 375,309 | +1677.2% | 0.00% | – |
| Q1 2016 | $61,000 | – | 21,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |